Tilray (NASDAQ:TLRY) Shares Down 0.3% – Should You Sell?

Tilray Inc (NASDAQ:TLRY) shares fell 0.3% during trading on Thursday . The stock traded as low as $1.66 and last traded at $1.68. 4,322,725 shares traded hands during trading, a decline of 83% from the average session volume of 25,068,988 shares. The stock had previously closed at $1.68.

Tilray Trading Down 0.3 %

The stock has a 50-day simple moving average of $1.79 and a 200 day simple moving average of $1.88. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The company has a market cap of $1.31 billion, a price-to-earnings ratio of -3.85 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.15) EPS. As a group, equities research analysts predict that Tilray Inc will post -0.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Tilray

Several institutional investors and hedge funds have recently modified their holdings of TLRY. Tidal Investments LLC grew its position in shares of Tilray by 36,687.0% in the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock valued at $26,373,000 after purchasing an additional 10,648,403 shares in the last quarter. Bank of Montreal Can grew its position in shares of Tilray by 19.6% in the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after purchasing an additional 355,778 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Tilray in the first quarter valued at approximately $586,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Tilray by 8.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after purchasing an additional 213,834 shares in the last quarter. Finally, J.W. Cole Advisors Inc. grew its position in shares of Tilray by 1,077.2% in the second quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock valued at $284,000 after purchasing an additional 156,524 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.